Zhi Tong Cai Jing·2025-08-29 09:29Core Viewpoint - Recently, the company’s subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (referred to as "Tianxin Pharmaceutical"), received a Drug Production License from the Guangdong Provincial Drug Administration, allowing it to contract manufacture drugs (limited to registered products) and to renovate its small-volume injection production line three [1] Group 1 - Tianxin Pharmaceutical's small-volume injection production line three and oral solid dosage workshop for granules (cephalosporin type) have passed the compliance inspection for drug production quality management standards [1] - The approval of the Drug Production License will help Tianxin Pharmaceutical optimize its production capacity to meet market demand [1] - The impact of this license on the company's current performance is not significant [1]